Kano Therapeutics
kanotherapeutics.comLocations
Cambridge, MA, USA · Cambridge, MA, USA
industry
Biotechnology
Size
11 - 50 employees
Stage
Seed
founded in
2021
Kano Therapeutics focuses on the correction of gene-length DNA using circular single-stranded DNA biomaterials. The company provides a comprehensive platform that combines manufacturing, application, and computational tools for genetic payload development. This approach empowers researchers and organizations to advance genetic cures effectively and safely.
Something looks off?Open jobs at Kano Therapeutics
On-site & Remote
Seniority
Salary